MedPage Today on MSN
Better Survival in Refractory CRC With Chemo Plus Bevacizumab, Real-World Study Says
OS of 8.9 months versus 5.8 months with trifluridine/tipiracil alone, supporting phase III ...
The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...
Unlock the full power of your Meta Quest 3 or 3S with these tweaks, downloads, and hidden settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results